Was Jim Cramer Right About Boston Scientific Corporation (BSX)?
We recently published a list of 12 Stocks Jim Cramer Was Right About.
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 7,948,162 | $801,810,582 | -11% | 1.02% |
| 2. | Millennium Management Israel Englander | 8,344,156 | $791,318,458 | -9% | 0.42% |
| 3. | Fisher Asset Management Ken Fisher | 6,765,550 | $682,508,788 | +17% | 0.3% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 6,754,655 | $681,409,596 | +21% | 0.55% |
| 5. | Citadel Investment Group Ken Griffin | 5,433,555 | $548,137,028 | +11% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.29 | 50 | Officer | 148,168 | 2024-12-03 | Filing | |
| $41.98 | 25,000 | Director | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | Director | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | Director | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | Director | 32,294 | 2017-04-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $102.88 | 56,372 | Officer | 178,342 | 2025-06-04 | Filing | |
| $103.39 | 89,921 | Officer, Director | 1,476,882 | 2025-06-02 | Filing | |
| $104.05 | 74,522 | Officer, Director | 1,566,803 | 2025-06-02 | Filing | |
| $104.59 | 4,000 | Director | 22,479 | 2025-05-29 | Filing | |
| $106.42 | 4,826 | Officer | 31,367 | 2025-05-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 141,671,066 | $14,291,777,135 | 0.3% | |
| 2. | 134,588,729 | $13,577,310,982 | 0.25% | |
| 3. | 128,597,214 | $12,972,886,977 | 0.83% | |
| 4. | 64,478,485 | $6,504,589,567 | 0.27% | |
| 5. | 36,496,946 | $3,681,811,912 | 3.04% |
News See All
12 Stocks Jim Cramer Was Right About
During the latest episode of Mad Money, which aired on Thursday, the 15th of May 2025, Jim Cramer gave some advice on how investors should be approaching the markets from a psychological perspective...
What Makes Boston Scientific Corporation (BSX) A Compelling Name Within The Large-Cap Medical Device Space?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
11 Best Medical Device Stocks to Buy Now
On April 16, CNBC reported that Trump's tariffs are building a divide in the medical community.
Boston Scientific Corporation (NYSE:BSX) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Boston Scientific First Quarter 2025 Earnings Call. Please note this event is being recorded.
12 Best Stocks Under $100 to Buy According to Hedge Funds
On April 21, Chris Davis of Davis Advisors appeared on 'The Exchange' on CNBC to talk about selectivity in today’s market.
10 Best Low Volatility Stocks to Buy Now
The US stock market experienced a turbulent first quarter of 2025, marked by increased volatility and negative returns across the major indices.
10 Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.
Boston Scientific Corporation (BSX): A Bull Case Theory
We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BSX.
10 Best Healthcare Stocks to Buy According to Billionaires
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
Billionaire Hedge Funds
